The Food and Drug Administration on Wednesday canceled a planned March 13 committee meeting to update next winter's flu shot.

The annual spring meeting is a critical part of updating the yearly flu shot to match the strains most likely to be circulating in the U.S. come wintertime.

Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...

If HHS doesn’t make any flu strain recommendations, companies will likely have to rely on those made by the World Health Organization (WHO), which is meeting this week. On his first day in office, ...

A government advisory committee has canceled a meeting on flu shot recommendations, raising concerns amid shifts in ...

Each year, flu vaccines are tailored to match the most prevalent virus strains expected to circulate. Without an official ...

The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...

The FDA canceled a critical annual flu vaccine planning meeting without explanation days after Robert F. Kennedy Jr. took ...

The March meeting was set to vote on which flu strains would offer the most protection for next season’s flu shot.

Trump administration policy moves to dismantle education department as states face uncertainty, FDA cancels crucial vaccine ...

The sticker-shock warning came amid the unveiling of a new plan by the Trump administration to alleviate egg prices, which ...

Disruptions to government-sanctioned advisory committee meetings on vaccines are becoming increasingly common after the ...